Max Healthcare Institute Limited reported earnings results for the third quarter and nine months ended December 31, 2025. For the third quarter, the company reported sales was INR 20,675.2 million compared to INR 18,683.1 million a year ago. Revenue was INR 21,129 million compared to INR 19,016.1 million a year ago. Net income was INR 3,009.2 million compared to INR 2,388 million a year ago. Basic earnings per share from continuing operations was INR 3.1 compared to INR 2.46 a year ago. Diluted earnings per share from continuing operations was INR 3.09 compared to INR 2.44 a year ago.
For the nine months, sales was INR 62,305.6 million compared to INR 51,187.2 million a year ago. Revenue was INR 63,453.5 million compared to INR 52,275.4 million a year ago. Net income was INR 11,001.9 million compared to INR 7,568.8 million a year ago. Basic earnings per share from continuing operations was INR 11.32 compared to INR 7.79 a year ago. Diluted earnings per share from continuing operations was INR 11.26 compared to INR 7.74 a year ago.
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company offers an integrated suite of diagnostics and lab services, ambulatory care, consultations, surgical and non-surgical procedures, and medical treatment. Its clinical offerings span a range of therapeutic areas, including radiation therapy for cancer, and specialized treatments in oncology, neurosciences, cardiac sciences, orthopedics, renal and liver care and minimally invasive surgery. It also provides consultations across diverse medical specialties such as diabetes and endocrinology, pulmonology, nephrology, dermatology, gastroenterology, physiotherapy and rehabilitation. It also caters to specific healthcare needs, including transplant services, audiology and speech therapy, and dedicated pediatric care. It offers a home care program through Max@Home, enabling patients to receive medical attention in the comfort of their homes. Its Max Lab provides at-home diagnostic testing.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
